Prof. Naomi Haas (US) discusses the findings on the study “variation in recurrence rate and overall survival (OS) outcomes by disease stage and incremental impact of time to recurrence on OS in localised RCC,” which she has just presented at ASCO22.
Prof. Naomi Haas (US) discusses the findings on the study “variation in recurrence rate and overall survival (OS) outcomes by disease stage and incremental impact of time to recurrence on OS in localised RCC,” which she has just presented at ASCO22.